KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Short term Debt (2018 - 2025)

Historic Short term Debt for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to $6.3 million.

  • Aquestive Therapeutics' Short term Debt rose 2520800.0% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 2520800.0%. This contributed to the annual value of $26000.0 for FY2024, which is 1818.18% up from last year.
  • Per Aquestive Therapeutics' latest filing, its Short term Debt stood at $6.3 million for Q3 2025, which was up 2520800.0% from $3.2 million recorded in Q2 2025.
  • Aquestive Therapeutics' 5-year Short term Debt high stood at $18.7 million for Q4 2022, and its period low was $22000.0 during Q4 2023.
  • Over the past 5 years, Aquestive Therapeutics' median Short term Debt value was $4.6 million (recorded in 2023), while the average stood at $6.2 million.
  • As far as peak fluctuations go, Aquestive Therapeutics' Short term Debt plummeted by 9988.24% in 2023, and later surged by 2520800.0% in 2025.
  • Aquestive Therapeutics' Short term Debt (Quarter) stood at $2.0 million in 2021, then soared by 823.46% to $18.7 million in 2022, then crashed by 99.88% to $22000.0 in 2023, then rose by 18.18% to $26000.0 in 2024, then soared by 24234.62% to $6.3 million in 2025.
  • Its Short term Debt stands at $6.3 million for Q3 2025, versus $3.2 million for Q2 2025 and $27000.0 for Q1 2025.